不同类型的首次激活COVID-19疫苗接种:初始反应性数据
Robert H Shaw1, Arabella Stuart1, Melanie Greenland1
1Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
Lancet (London, England)
|May 15, 2021
概括
No abstract available in PubMed .
相关概念视频
Vaccinations
48.6K
Overview
48.6K
Dose-Response Relationship: Potency and Efficacy
5.8K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.8K
Cross-reactivity
31.9K
Overview
31.9K
Bioequivalence studies: Biowaivers
49
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
49


